AXREF
AMARC RESOURCES LTD
$0.7200
0.00%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 11, 2026
SEC
Amarc Resources appointed Tom McMillan as VP of Investor Relations ahead of its 2026 exploration program at the JOY and
6-K — Impact 3/10
Apr 22, 2026
SEC
Amarc Resources Ltd. announced its common shares have commenced trading on the Frankfurt Stock Exchange under the symbol
6-K — Impact 4/10
Apr 2, 2026
SEC
Amarc Resources confirmed Boliden's continued participation in the DUKE Copper-Gold District joint venture, with a 60%/4
6-K — Impact 6/10
Latest Reports
NEUTRAL
6-K
3/10
Amarc Resources appointed Tom McMillan as VP of Investor Relations ahead of its 2026 exploration program at the JOY and
May 11, 2026
NEUTRAL
6-K
4/10
Amarc Resources Ltd. announced its common shares have commenced trading on the Frankfurt Stock Exchange under the symbol
Apr 22, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.3/10.
NEUTRAL
6-K
3/10
Amarc Resources appointed Tom McMillan as VP of Investor Relations ahead of its 2026 exploration pro
May 11, 2026
NEUTRAL
6-K
4/10
Amarc Resources Ltd. announced its common shares have commenced trading on the Frankfurt Stock Excha
Apr 22, 2026
BULLISH
6-K
6/10
Amarc Resources confirmed Boliden's continued participation in the DUKE Copper-Gold District joint v
Apr 2, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.